Literature DB >> 7004811

Improved control in diabetes with continuous subcutaneous insulin infusion.

A Schiffrin, E Colle, M Belmonte.   

Abstract

Nine insulin-dependent diabetic patients were treated with continuous subcutaneous (s.c.) insulin infusion, using a portable battery-driven infusion pump and home monitoring of capillary blood glucose. The infusions were maintained for 4 days during an acute in-hospital study and for up to 150 days on ambulatory patients. No significant changes in growth hormone and cortisol secretory patterns were found at the end of the acute study. Mean plasma glucose, M values, and glycosylated hemoglobin A1 (HbA1), as well as the patients' sense of well-being, improved significantly. However, absolute normalization of metabolic control was not achieved, since patients presented occasional, albeit minor, swings of blood glucose. The possibility that the same improvement in control could be achieved with multiple s.c. injections of insulin and similar monitoring of blood glucose in the home is discussed. It remains to be seen whether the degree of control obtained will influence the development of the late complications of diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7004811     DOI: 10.2337/diacare.3.6.643

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  3 in total

Review 1.  Optimisation of treatment by applying programmable rate-controlled drug delivery technology.

Authors:  Yie W Chien; Senshang Lin
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy.

Authors:  E W Kraegen; D J Chisholm
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

3.  Metabolic rhythms in adolescents with diabetes.

Authors:  M D Hocking; P H Rayner; M Nattrass
Journal:  Arch Dis Child       Date:  1986-02       Impact factor: 3.791

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.